Senti Biosciences Holdings, Inc. — Form 8-K
Filed October 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Form 8-K filed 2026-10-27 disclosing Items 5.02 and 8.01 regarding departure of directors or officers and appointment of certain officers with compensatory arrangements, and other events. The filing document metadata is present but specific names, dollar amounts, dates of departure, positions, and compensation details are not extractable from the header/index information provided.
Why this rating
Officer/director changes are routine; without specific details (names, role seniority, compensation magnitude), cannot assess materiality relative to $53.2M market cap.
Extracted items
- 5.02 exec change
- 8.01 other event
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.